Physician

Danubia Hester

According to 2025 Medicare claims, Danubia Hester (NPI: 1326426057) practices internal medicine in the Washington, DC-MD market, with the plurality of this provider's patient population coming from Prince Georges, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY, P.A. (NPI: 1821271032; TIN: 113652573) and primary practice location at 20613-3045.

Hester's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 622 traditional Medicare patients, billed 111,957 HCPCS/CPT codes, and received $1,637,584 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 424 prescription claims across 69 beneficiaries totaling $1,051,564 in drug costs, led by Lorbrena (Lorlatinib). Open Payments data shows 122 records totaling $2,952. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,053 to $1,637,584. Similarly, Part D prescription costs have risen steadily, from $1,812 to $1,051,564. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$874K$1.7M2018 Medicare payment: $3,053 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,492 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,068 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,901 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $15,066 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,747,098 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,637,584 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181647$3,053
20193571$5,492
20201921$2,068
20211921$1,901
2022251,714$15,066
2023620144,340$1,747,098
2024622111,957$1,637,584

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$526K$1.1M2015 Drug cost: $1,812 (USD; Tot_Drug_Cst)2016 Drug cost: $4,785 (USD; Tot_Drug_Cst)2017 Drug cost: $1,405 (USD; Tot_Drug_Cst)2019 Drug cost: $13,498 (USD; Tot_Drug_Cst)2020 Drug cost: $5,375 (USD; Tot_Drug_Cst)2021 Drug cost: $58,451 (USD; Tot_Drug_Cst)2023 Drug cost: $193,881 (USD; Tot_Drug_Cst)2024 Drug cost: $1,051,564 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R28$1,812
20162372$4,785
20171952$1,405
2018N/RN/RN/R
2019N/R13$13,498
20201832$5,375
20211221$58,451
2022N/RN/RN/R
202346156$193,881
202469424$1,051,564

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more225389$105
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more133151$77
96372Injection of drug or substance under skin or into muscle171277$12
80053Blood test, comprehensive group of blood chemicals187609$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count202860$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LorbrenaLorlatinib14420$346,895
TasignaNilotinib Hcl14392$280,503
EliquisApixaban381,260$24,087
AnastrozoleAnastrozole282,226$593
Oxycodone HclOxycodone Hcl30526$587

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.122$2,952Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Danubia Hester?

Tedicare shows public-source Medicare data for Danubia Hester (NPI 1326426057), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Danubia Hester have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Danubia Hester?

Danubia Hester is linked to MARYLAND ONCOLOGY HEMATOLOGY, P.A. (billing NPI 1821271032) in the available physician profile data.

Does Danubia Hester have Open Payments data?

Danubia Hester has 122 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.